Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size

NCT02021942 is registered in ClinicalTrials.gov with Prof. Dr. Berthold Schalke as lead sponsor.

NCT NCT02021942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02021942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size
Lead sponsor
Prof. Dr. Berthold Schalke
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2012
Completion date
October 31, 2015
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

local recurrent thymoma, primary inoperable thymoma